PT - JOURNAL ARTICLE AU - Wilson-Aggarwal, Jared AU - Gotts, Nick AU - Arnold, Kellyn AU - Spyer, Moira J AU - Houlihan, Catherine F AU - Nastouli, Eleni AU - Manley, Ed TI - Assessing the spatial-temporal risks of SARS-CoV-2 infection for healthcare-workers in the hospital using behavioural indices from routine data AID - 10.1101/2022.11.10.22282176 DP - 2022 Jan 01 TA - medRxiv PG - 2022.11.10.22282176 4099 - http://medrxiv.org/content/early/2022/11/11/2022.11.10.22282176.short 4100 - http://medrxiv.org/content/early/2022/11/11/2022.11.10.22282176.full AB - The COVID-19 pandemic has emphasised the need to rapidly assess infection risks for healthcare workers within the hospital environment. Using data from the first year of the pandemic, we investigated whether an individual’s COVID-19 test result was associated with behavioural markers derived from routinely collected hospital data two weeks prior to a test. The temporal and spatial context of behaviours were important, with the highest risks of infection during the first wave, for staff in contact with a greater number of patients and those with greater levels of activity on floors handling the majority of COVID-19 patients. Infection risks were higher for BAME staff and individuals working more shifts. Night shifts presented higher risks of infection between waves of COVID-19 patients. Our results demonstrate the epidemiological relevance of deriving markers of staff behaviour from electronic records, which extend beyond COVID-19 with applications for other communicable diseases and in supporting pandemic preparedness.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the UCLH/UCL NIHR Biomedical Research Centre and funding from the UKRI MRC (grant ref: MC_PC_19082), and UCLH Charity.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the NHS Health Research Authority (South Central, Berkshire REC ref 20/SC/0147, protocol number 130861) and ethical oversight was provided by the UCLH research ethics committee (IRAS project ID: ref. 281836). UCL GOS ICH R&D approval number 20PL06.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available from UCLH but restrictions apply to protect the privacy of individuals, and the data are not publicly available. Data are however available from the authors upon reasonable request and with permission from UCLH.